510(K) CLEARANCES 75 ▼9RECALLS POSTED 26 ▼13CLASS I 2 ▼4PMA DECISIONS 54 ▲7WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K024098Substantially Equivalent

Cobas Integra Creatinine Plus Ver.2 Assay

Roche Diagnostics GmbH, Indianapolis IN / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K024098 is the FDA 510(k) clearance record for COBAS INTEGRA CREATININE PLUS VER.2 ASSAY, a class II device, cleared for Roche Diagnostics Corp. on under FDA product code JFY (Enzymatic Method, Creatinine). FDA records list 465 510(k) clearances for Roche Diagnostics Corp., from to . As of , FDA records show 2 recalls naming K024098.

Clearance record

Decision date
Received
(7 days to decision)
Product code
JFY Enzymatic Method, Creatinine
Regulation
21 CFR 862.1225
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Roche Diagnostics Corp. 9115 Hague Rd., Indianapolis IN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code JFY

Trailing 12 months
1 clearance under product code JFY in the twelve months to October 2026, February 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code JFY, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20261
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260